Literature DB >> 8878072

Further evidence for the subsensitivity of striatal AMPA receptors, induced by chronic haloperidol administration: an autoradiographic study.

K Ossowska1, M Pietraszek, J Wardas.   

Abstract

The aim of the present study was to investigate the influence of chronic treatment with haloperidol on the striatal N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxasole-propionic acid (AMPA) and dopamine D2 receptors using a quantitative autoradiography in rats. Haloperidol was given to animals in a dose of ca. 1 mg/kg/day in drinking water for 6 weeks or 3 months and was afterwards withdrawn for 5 days. Haloperidol increased by 20-50% the binding of [3H]spiperone in different regions of the caudate-putamen. Haloperidol decreased by ca. 30% the binding of [3H]AMPA in the ventrolateral region of intermediate part of the caudate-putamen, but did not influence the binding of [3H]MK-801. The present results suggest that, apart from supersensitivity to dopamine, chronic treatment with haloperidol also induces subsensitivity of striatal AMPA receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878072     DOI: 10.1007/bf00171073

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

Review 1.  The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones.

Authors:  A D Smith; J P Bolam
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

2.  Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease.

Authors:  T Klockgether; L Turski
Journal:  Trends Neurosci       Date:  1989-08       Impact factor: 13.837

3.  Depolarization inactivation of dopamine neurons: terminal release characteristics.

Authors:  B Moghaddam; B S Bunney
Journal:  Synapse       Date:  1993-07       Impact factor: 2.562

4.  Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors.

Authors:  R E See; M Aravagiri; G D Ellison
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

5.  Development of NMDA receptor-channel complex and L-type calcium channels in mouse hippocampus.

Authors:  S Głazewski; J Skangiel-Kramska; M Kossut
Journal:  J Neurosci Res       Date:  1993-06-01       Impact factor: 4.164

6.  The influence of dizocilpine (MK-801) on the reserpine-enhanced electromyographic stretch reflex in rats.

Authors:  K Ossowska; E Lorenc-Koci; G Schulze; S Wolfarth
Journal:  Neurosci Lett       Date:  1996-01-19       Impact factor: 3.046

Review 7.  The role of excitatory amino acids in experimental models of Parkinson's disease.

Authors:  K Ossowska
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1994

8.  Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain.

Authors:  A E Johnson; U Liminga; A Lidén; N Lindefors; L M Gunne; F A Wiesel
Journal:  Neuroscience       Date:  1994-12       Impact factor: 3.590

9.  NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum.

Authors:  G B Landwehrmeyer; D G Standaert; C M Testa; J B Penney; A B Young
Journal:  J Neurosci       Date:  1995-07       Impact factor: 6.167

10.  Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.

Authors:  D J Laurie; P H Seeburg
Journal:  Eur J Pharmacol       Date:  1994-08-16       Impact factor: 4.432

View more
  1 in total

Review 1.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.